Related Experiment Video
Updated: Sep 16, 2025

Measuring Skeletal Muscle Thermogenesis in Mice and Rats
Published on: July 27, 2022
Imidazoline 1 receptors mediate the hyperthermia induced by preoptic agmatine application in male rats
Jianhui Xu1, Nanping Wang2, Qiaofeng Ji2
1Key Laboratory of Thermoregulation and Inflammation at Chengdu Medical College of Sichuan Province, Chengdu, Sichuan, 610500, PR China; Development and Regeneration Key Laboratory of Sichuan Province, Chengdu Medical College, Chengdu, Sichuan, 610500, PR China.
Abstract:
Previous studies have confirmed that microinjection of agmatine into the preoptic area (POA) induces hyperthermia in male rats, yet its receptor mechanism is known little. In the present study, using agonists and antagonists for imidazoline receptors (IRs) and α2-adrenoceptors (α2-ARs), to which agmatine binds with high affinity, we explored the roles of IRs and α2-ARs in hyperthermia induced by intra-POA agmatine in male rats. We found that intra-POA administration of the I1R agonist moxonidine elevated the core temperature and physical activity in conscious rats, enhanced brown adipose tissue (BAT) thermogenesis and shivering in anesthetized rats, and depressed the warm-sensitive neurons (WSNs) in POA slices in vitro, which aligned with previously demonstrated agmatine effects. Meanwhile, the selective I1R antagonist AGN192403 attenuated these effects. Moreover, fluorescence immunohistochemical analysis of Nischarin (a natural functional I1R) indicated that I1Rs were distributed in the POA. However, neither agonists nor antagonists for I2R or α2-ARs mimicked or attenuated the effects of intra-POA agmatine. In conclusion, we demonstrated that it is I1R rather than I2R or α2-ARs that mediates intra-POA agmatine-induced hyperthermia by elevating physical activity, BAT thermogenesis and shivering, likely through depression of POA WSNs. These results indicate an important role of the preoptic agmatine-I1R system in the thermoregulation.
Related Concept Videos
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Direct-Acting Cholinergic Agonists: Pharmacological Actions
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...

